Skip to main content
Premium Trial:

Request an Annual Quote

VWR to Sell Bioneer's Wares in North American Market

NEW YORK (GenomeWeb News) - Lab products vendor VWR will distribute Bioneer’s genomics tools and custom oligonucleotides in North America through an exclusive agreement, Bioneer said this week.
 
Under the “long-term” deal, the West Chester, Penn.-based VWR will exclusively market Bioneer’s products in the US, Canada, and Mexico. These products include DNA and RNA oligonucleotides, PCR-based products, DNA/RNA isolation and purification tools, and other molecular biology equipment.
 
Bioneer said the agreement allows it to continue to supply its own customer base.
 
The agreement was signed between VWR and Bioneer Inc., a wholly owned subsidiary of Korea's Bioneer Corp. based in Alameda, Calif.  

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.